Board of Directors
Calvin W. Roberts, MD
Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience.
Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical and surgical business units.
As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and post-operative cystoid macular edema.
Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He serves as an Independent Director on multiple corporate boards and as a consultant to Allergan, Johnson & Johnson, and Novartis. He was included on Crain’s New York Business 2021 list of Notable In Health Care, is honored to represent Lighthouse Guild on the American Academy of Ophthalmology’s Vision Rehabilitation Committee, and is the recipient of the John Milton McLean Medal for 2024, the most prestigious prize offered by the Weill Cornell Department of Ophthalmology.
A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.